These mitochondrial protective features of BI1, in conjunction with the fact that BI1 could be detected in urine sediments and plasma in human, might provide a potential target for clinical monitoring and therapeutic evaluation of AKI. The gene discussed is TMBIM6; the disease is acute kidney injury.